Personal jurisdiction fans and the tort bar eagerly awaited the U.S. Supreme Court’s decision last month in Bristol-Myers Squibb v. Superior Court of California, 137 S. Ct. 1773.
This website uses cookies to improve your experience on the site. By continuing to use this site, you agree to the use of cookies. To learn more about how we use cookies, please see our Cookie Policy.